HBIO Historical Earnings image   This HBIO historical earnings page last updated 5/9/2024
HBIO Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20245/7/20240.02B
Q4 20233/7/20240.03B
Q3 202311/7/20230.03B
Q2 20238/8/20230.03B
Q1 20234/25/20230.03B
Q4 20223/9/20230.03B
Q3 202211/8/20220.03B
Q2 20228/3/20220.03B
Q1 20225/4/20220.03B
Q4 20213/8/20220.03B
Q3 202111/3/20210.03B
Q2 20218/5/20210.03B
Q1 20215/6/20210.03B
Q4 20203/10/20210.03B
Q3 202011/5/20200.02B
Q2 20208/5/20200.02B
Q1 20205/5/20200.02B
Q4 20192/26/20200.03B
Q3 201911/5/20190.03B
Q2 20197/25/20190.03B
Q1 20195/2/20190.03B
Q4 20182/28/201933.94M
Q3 201810/25/201828.71M
Q2 20187/26/201831.52M
Q1 20185/2/201826.76M
Q4 20173/1/201827.46M
Q3 201710/26/201725.05M
Q2 20177/27/201725.21M
Q1 20174/27/201724.16M
Q4 20163/9/201726.41M
Q3 201610/27/201625.01M
Q2 20167/28/201626.14M
Q1 20165/12/201626.96M
Q4 20154/12/201628.37M
Q3 201510/29/201525.73M
Q2 20157/30/201528.80M
Q1 20154/30/201525.80M
Q4 20142/26/201530.36M
Q3 201410/30/201425.40M
Q2 20147/31/201427.00M
Q1 20145/1/201425.89M
Q4 20132/27/201427.90M
Q3 201310/31/201325.10M
Q2 20138/1/201326.10M
Q1 20135/2/201326.10M
Q4 20122/28/201328.25M
Q3 201211/1/201226.10M
HBIO Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q1 20245/7/20240.020
Q4 20233/7/20240.040
Q3 202311/7/20230.010
Q2 20238/8/20230.040
Q1 20234/25/20230.060
Q4 20223/9/20230.040
Q3 202211/8/2022-0.010
Q2 20228/3/20220.050
Q1 20225/4/20220.040
Q4 20213/8/20220.080
Q3 202111/3/20210.060
Q2 20218/5/20210.060
Q1 20215/6/20210.050
Q4 20203/10/20210.080
Q3 202011/5/20200.040
Q2 20208/5/20200.050
Q1 20205/5/2020-0.010
Q4 20192/26/20200.080
Q3 201911/5/20190.040
Q2 20197/25/20190.040
Q1 20195/2/20190.020
Q4 20182/28/20190.07
Q3 201810/25/20180.04
Q2 20187/26/20180.07
Q1 20185/2/20180.03
Q4 20173/1/20180.05
Q3 201710/26/20170.03
Q2 20177/27/20170.03
Q1 20174/27/20170.02
Q4 20163/9/20170.04
Q3 201610/27/20160.03
Q2 20167/28/20160.03
Q1 20165/12/20160.05
Q4 20154/12/20160.03
Q3 201510/29/20150.03
Q2 20157/30/20150.05
Q1 20154/30/20150.02
Q4 20142/26/20150.1
Q3 201410/30/20140.06
Q2 20147/31/20140.06
Q1 20145/1/20140.05
Q4 20132/27/20140.05
Q3 201310/31/20130.05
Q2 20138/1/2013-0.01
Q1 20135/2/20130.03
Q4 20122/28/20130.01
Q3 201211/1/20120.04
Quotes delayed 20 minutes

Email EnvelopeFree HBIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Harvard Bioscience (HBIO) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

HCA Historical Earnings
HCWB Historical Earnings
HEPA Historical Earnings
HGEN Historical Earnings
HJLI Historical Earnings
HLTH Historical Earnings
HLVX Historical Earnings
HNGR Historical Earnings
HOLX Historical Earnings
HOOK Historical Earnings
What was the record high HBIO historical earnings result?
In terms of earnings or revenue, what is the best HBIO historical earnings result that Harvard Bioscience has ever posted, and when?

✔️Accepted answer: Within our data set, the highest HBIO historical earnings result was set in Q4 2014, when Harvard Bioscience posted results of 0.1/share. The most successful revenue quarter within our data set was Q4 2018 when Harvard Bioscience reported revenue of 33.94M.

What was the lowest Harvard Bioscience historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest HBIO has reported, and when?

✔️Accepted answer: Within our data set, the lowest HBIO historical earnings result was set in Q3 2022, when Harvard Bioscience posted results of -0.010/share. The smallest revenue quarter within our data set was Q2 2020 when Harvard Bioscience reported revenue of 0.02B.

On this page we presented the HBIO historical earnings date information for Harvard Bioscience. Reviewing that HBIO Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2014, when HBIO posted adjusted EPS of 0.1/share. Meanwhile the lowest HBIO historical earnings result was in Q3 2022, when HBIO posted adjusted EPS of -0.010/share. Moving to Harvard Biosciences historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2018 when HBIO reported 33.94M in revenue, while the smallest revenue quarter was Q2 2020 when HBIO reported 0.02B in revenue.

For self directed investors doing their due diligence on HBIO or any other given stock, their research can benefit from looking into all of the Harvard Bioscience historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Harvard Bioscience historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for HBIO. Thanks for visiting, and the next time you need to research HBIO historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: RDWR Stock Predictions, NBHC Dividend History, DVY Historical Stock Prices.


HBIO Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.